HPCM
Hunter Perkins Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,115
| Closed | -$4.76M | – | 110 |
|
|
2025
Q1 | $4.76M | Sell |
78,115
-100,435
| -56% | -$6.13M | 1.11% | 33 |
|
|
2024
Q4 | $10.1M | Sell |
178,550
-19,000
| -10% | -$1.07M | 2.12% | 16 |
|
|
2024
Q3 | $10.2M | Buy |
197,550
+142,525
| +259% | +$7.37M | 2.07% | 16 |
|
|
2024
Q2 | $2.29M | Sell |
55,025
-950
| -2% | -$39.5K | 0.48% | 47 |
|
|
2024
Q1 | $3.04M | Sell |
55,975
-2,850
| -5% | -$155K | 0.62% | 45 |
|
|
2023
Q4 | $3.02M | Sell |
58,825
-35,350
| -38% | -$1.81M | 0.63% | 44 |
|
|
2023
Q3 | $5.47M | Sell |
94,175
-38,720
| -29% | -$2.25M | 1.17% | 29 |
|
|
2023
Q2 | $5.36M | Buy |
132,895
+83,710
| +170% | +$3.37M | 1.14% | 26 |
|
|
2023
Q1 | $3.41M | Buy |
49,185
+2,875
| +6% | +$199K | 0.8% | 31 |
|
|
2022
Q4 | $3.33M | Sell |
46,310
-31,100
| -40% | -$2.24M | 0.75% | 36 |
|
|
2022
Q3 | $5.5M | Sell |
77,410
-2,125
| -3% | -$151K | 1.35% | 24 |
|
|
2022
Q2 | $6.15M | Sell |
79,535
-48,525
| -38% | -$3.75M | 1.42% | 23 |
|
|
2022
Q1 | $9.35M | Buy |
128,060
+17,125
| +15% | +$1.25M | 1.88% | 20 |
|
|
2021
Q4 | $6.92M | Buy |
+110,935
| New | +$6.92M | 1.3% | 25 |
|